Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer.
Wakefield
L M
LM
Laboratory of Chemoprevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Sporn
M B
MB
D000818:Animals; D002450:Cell Communication / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003864:Depression, Chemical; D004848:Epithelium / Q000187:drug effects; D005109:Extracellular Matrix / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D016161:Genes, Retinoblastoma; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007365:Intercellular Junctions / Q000187:drug effects; D007399:Interphase / Q000187:drug effects; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control*; D011230:Precancerous Conditions / Q000188:drug therapy*; D012176:Retinoids / Q000494:pharmacology; D013256:Steroids / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use
D012176:Retinoids; D013256:Steroids; D016212:Transforming Growth Factor beta